Trade DFTX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Definium Therapeutics, Inc. Common Shares (DFTX) is trading at US$34.33, up 0.25% today as of Oct 15, 10:54 EDT. The company has a market capitalisation of US$6.03B. Over the past 52 weeks, DFTX has traded between US$10.46 and US$49.70. On Syfe you can trade DFTX with $0 commission and add it to your watchlist.
| Previous close | US$34.24 |
|---|---|
| Market cap | US$6.03B |
| 52-week range | US$10.46 – US$49.70 |
| Volume | 1.76M |
| Exchange | US |
Definium Therapeutics, Inc. Common Shares
Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.
Year: 2020
Sector Update: Healthcare Stocks Rise in Afternoon Trading
Sep 14, 5:49 PM · MT Newswires
Sector Update: Healthcare
Sep 14, 5:09 PM · MT Newswires
Top Midday Stories: No OpenAI IPO in 2026, Altman Reportedly Says; Nvidia, Palantir Said to Restrict AI Usage Over Customer Data Fears
Sep 14, 3:56 PM · MT Newswires
Stay on top of DFTX
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
